WWW - Posts tagged Halozyme at BloggingStocks

halozyme posts

Market highlights for next week: Yahoo CEO to testify before Congress

Posted Nov 2nd 2007 3:00PM by Eric Buscemi (RSS feed)
Filed under: Earnings Reports, Forecasts, Conventions and Conferences, Annual Meetings, Yahoo! (YHOO), Wal-Mart (WMT), Walt Disney (DIS), Gap Inc (GPS), Abercrombie and Fitch (ANF), Burger King Hldgs (BKC), Goldcorp Inc (GG)

Monday, November 5

BorgWarner (NYSE: BWA) to give business update at 10am.
Burger King (NYSE: BKC) to report Q1 earnings; conference call at 10am.

Tuesday, November 6

Merrill Lynch to host conference call discussing Focus Media's (NASDAQ: FMCN) secondary offering at 11am.
Yahoo (NASDAQ: YHOO) CEO Jerry Yang, Senior VP Michael Callahan & General Counsel to testify before the House Foreign Affairs Committee on how their company gave false information to Congress relating to their role in a human rights case in China which resulted in a journalist being sent to jail for 10 years.

Wednesday, November 7

Symmetry Medical (NYSE: SMA) to give Q3 business update at 8am.
Fluor (NYSE: FLR) to report Q3 earnings; conference call at 9:30am.
Hot Topic (NASDAQ: HOTT) to report October sales at 4pm, American Eagle (NASDAQ: AEO) to report Oct. sales at 5pm.

Thursday, November 8

Disney (NYSE: DIS) to report Q4 earnings; conference call at 4:30pm.
CyberSource (NASDAQ: CYBS) to give 2007 guidance at 4:30pm.
Gap (NYSE: GPS) and Wal-Mart Stores (NYSE: WMT) to report Oct. sales at 8am, Abercrombie & Fitch (NYSE: ANF) to report Oct. sales at 8:15am.

Friday, November 9

Halozyme Therapeutics (NASDAQ: HALO) to give business update at 11am.
Goldcorp (NYSE: GG) to report Q3 earnings; conference call at 1pm.

Analyst initiations 7-24-07: CELL, DFS, MA and X

Posted Jul 24th 2007 11:11AM by Kevin Shult (RSS feed)
Filed under: Analyst Reports, MasterCard Inc'A' (MA), U.S. Steel (X), Analyst Initiations

MOST NOTEWORTHY: Halozyme Therapeutics (HALO), Rosetta Genomics (ROSG), U.S. Steel (X) and BioFuel Energy (BIOF) were today's noteworthy initiations:

Halozyme (NASDAQ: HALO) was initiated with a Buy rating and $14 target at Oppenheimer. The firm is positive on Halozyme's prospects for signing additional multi-product Enhanze deals in the next 12 months and the company's expanding internal pipeline.

Oppenheimer also initiated shares of Rosetta Genomics (NASDAQ: ROSG) with a Buy rating and $11 target, as the firm is positive on Rosetta's intellectual property position in the emerging microRNA field related to the development and commercialization of research, diagnostic and therapeutic products, and other applications.

Goldman Sachs resumed coverage of U.S. Steel Group (NYSE: X) with a Neutral rating.

BioFuel Energy (NASDAQ: BIOF) was initiated with a Neutral rating at Cowen, as the firm sees a lack of catalysts until the company's plants under construction come on line in Q108...

OTHER INITIATIONS:

Brightpoint (NASDAQ: CELL) was initiated with an Outperform rating and $18 target at Credit Suisse.

MasterCard (NYSE: MA) was initiated with a Market Perform rating at Wachovia on valuation.

Citigroup initiated shares of Signature Bank (NASDAQ: SBNY) with a Buy rating and $39 target and shares of Discover Financial Services (NYSE: DFS) with a Sell rating and $24 target.